Terran Biosciences Steps Into 4-OH-DiPT Prodrug Arena With New Patent Application

As Reunion Neuroscience (NASDAQ: REUN) and Mindset Pharma (OTCMKTS: MSSTF) continue their court battle over claims on a novel 4-OH-DiPT prodrug, private biotech company Terran Biosciences has also filed a patent application over a proprietary polymorph, reported Noah Smith. 4-HO-DiPT is a psychedelic compound with LSD and psilocin-like effects, but holding a shorter onset of action […]

MoonLake’s Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022

MoonLake Immunotherapeutics (NASDAQ: MLTX) has reportedly engaged an investment bank as the Swiss company looks for a potential sale. The company focuses on developing antibody-derived treatments for inflammatory skin conditions. The is in preliminary talks with pharmaceutical companies interested in a potential acquisition. Citing the sources, Reuters emphasized that a deal isn’t guaranteed and wished to […]

Republican Presidential Candidate Vivek Ramaswamy Founded Roivant In Discussions With Roche For $7B Stomach Disease(s) Drug Deal

Roivant Sciences Ltd (NASDAQ: ROIV), a biotech company founded by Vivek Ramaswamy, a Republican presidential candidate, is reportedly in discussions with Roche Holdings AG (OTC: RHHBY) regarding the potential sale of an experimental drug for a debilitating stomach disease.  The drug at the center of the talks is RVT-3101 for ulcerative colitis and Crohn’s disease. The deal, which may […]

Teva’s Strategic Evaluation: Israeli Pharma Company Mulls Divesting $2B Active Ingredients Unit

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is reportedly considering potential strategic options for its active pharmaceutical ingredients (API) unit, which could include a potential sale.  This news comes from individuals privy to the matter, who indicated that the current healthcare asset acquisitions continue despite the broader global slowdown in dealmaking.  Working with consultants, Teva is attempting […]

Haleon Contemplates Sale of Non-Core Businesses, Including Nicotinell Brand: A Strategy Shift Towards Core Products

Haleon Plc (NYSE: HLN), a consumer health company, is reportedly considering divesting some smoking cessation products as part of a strategy to sell non-core businesses. The company is working with an adviser to find potential buyers for the Nicotinell brand, which includes nicotine gum, patches, and lozenges. The Nicotinell brand’s sale, which draws interest from investment […]

Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More

World’s Largest Psychedelics Conference Boasts 12K Attendees The Multidisciplinary Association for Psychedelic Studies (MAPS) sponsored a Psychedelic Science conference in Denver last week, which gathered over 12,000 people from the entire psychedelics spectrum. The list of attendees included the most knowledgeable individuals in the field, as well as grassroots organizations, practitioners, scientists, politicians, veterans, celebrities, […]

Why Fidelity National Information Shares Are Gaining Today

Private equity groups are considering purchasing a majority stake in Worldpay from Fidelity National Information Services Inc (NYSE: FIS) at a valuation exceeding $15 billion. Advent, a U.S. buyout firm that once owned Worldpay, is reportedly studying a bid. Another potential bidder could be Chicago-based private equity group GTCR. If FIS accepts an offer, it would deviate from its plan announced […]

Crypto Giant FTX Rises From Ashes, Eyes Reclaiming Lost Billions With Jaw-Dropping Revival

Crypto exchange FTX (CRYPTO: FTT) is actively seeking to reestablish its principal international exchange platform. This initiative comes in the wake of the company’s turmoil due to allegations regarding the loss of nearly $9 billion of client funds before it crumbled last year. John J. Ray III, who was appointed CEO in November when FTX entered bankruptcy, told […]